Abstract:Background: Although recurrence rates after radiofrequency catheter ablation (RFCA) in patients with atrial fibrillation (AF) remain high, there are a limited number of novel, high-quality mathematical predictive models that can be used to assess early recurrence after RFCA in patients with AF. Purpose: To identify the preoperative serum biomarkers and clinical characteristics associated with post-RFCA early recurrence of AF and develop a novel risk model based on least absolute shrinkage and selection operator (LASSO) regression to select important variables for predicting the risk of early recurrence of AF after RFCA. Methods: This study collected a dataset of 136 atrial fibrillation patients who underwent RFCA for the first time at Peking University Shenzhen Hospital from May 2016 to July 2022. The dataset included clinical characteristics, laboratory results, medication treatments, and other relevant parameters. LASSO regression was performed on 100 cycles of data. Variables present in at least one of the 100 cycles were selected to determine factors associated with the early recurrence of AF. Then, multivariable logistic regression analysis was applied to build a prediction model introducing the predictors selected from the LASSO regression analysis. A nomogram model for early post-RFCA recurrence in AF patients was developed based on visual analysis of the selected variables. Internal validation was conducted using the bootstrap method with 100 resamples. The model’s discriminatory ability was determined by calculating the area under the curve (AUC), and calibration analysis and decision curve analysis (DCA) were performed on the model. Results: In a 3-month follow-up of AF patients (n = 136) who underwent RFCA, there were 47 recurrences of and 89 non-recurrences of AF after RFCA. P, PLR, RDW, LDL, and CRI-II were associated with early recurrence of AF after RFCA in patients with AF (p < 0.05). We developed a predictive model using LASSO regression, incorporating four robust factors (PLR, RDW, LDL, CRI-II). The AUC of this prediction model was 0.7248 (95% CI 0.6342–0.8155), and the AUC of the internal validation using the bootstrap method was 0.8403 (95% CI 0.7684–0.9122). The model demonstrated a strong predictive capability, along with favorable calibration and clinical applicability. The Hosmer–Lemeshow test indicated that there was good consistency between the predicted and observed values. Additionally, DCA highlighted the model’s advantages in terms of its clinical application. Conclusions: We have developed and validated a risk prediction model for the early recurrence of AF after RFCA, demonstrating strong clinical applicability and diagnostic performance. This model plays a crucial role in guiding physicians in preoperative assessment and clinical decision-making. This novel approach also provides physicians with personalized management recommendations.

Establishment and Evaluation of a Nomogram Prediction Model for Recurrence Risk of Atrial Fibrillation Patients after Radiofrequency Ablation.

Nomogram to predict recurrence risk factors in patients with non‐valvular paroxysmal atrial fibrillation after catheter radiofrequency ablation

A novel nomogram for predicting the recurrence of atrial fibrillation in patients treated with first-time radiofrequency catheter ablation for atrial fibrillation

Influencing Factors of Recurrence of Nonvalvular Atrial Fibrillation after Radiofrequency Catheter Ablation and Construction of Clinical Nomogram Prediction Model

Development and Validation of a Novel Nomogram for Predicting Recurrent Atrial Fibrillation after Cryoballoon Ablation.

A prediction model of atrial fibrillation recurrence after first catheter ablation by a nomogram--HASBLP score

Development and Validation of a Novel Prognostic Model Predicting the Atrial Fibrillation Recurrence Risk for Persistent Atrial Fibrillation Patients Treated with Nifekalant During the First Radiofrequency Catheter Ablation

Development and Validation of a Predictive Model Based on LASSO Regression: Predicting the Risk of Early Recurrence of Atrial Fibrillation after Radiofrequency Catheter Ablation

A Novel Predictive Model of Recurrence after Surgical Ablation of Valvular Atrial Fibrillation

Development and Validation of a Novel Prognostic Tool to Predict Recurrence of Paroxysmal Atrial Fibrillation after the First-Time Catheter Ablation: A Retrospective Cohort Study

Incremental Predictive Utility of a Radiomics Signature in a Nomogram for the Recurrence of Atrial Fibrillation.

Viable Prediction for Atrial Fibrillation Recurrence After Catheter Ablation

Development of a Nomogram That Predicts the Risk of Atrial Fibrillation in Patients with Coronary Heart Disease

Establishment and evaluation of a nomogram for in-hospital new-onset atrial fibrillation after percutaneous coronary intervention for acute myocardial infarction

Related factors Analysis of recurrent atrial fibrillation after radiofrequency catheter ablation

A predictive model using left atrial function and B‐type natriuretic peptide level in predicting the recurrence of early persistent atrial fibrillation after radiofrequency ablation

A Predictive Model for Recurrence of Atrial Fibrillation Based on P-Wave Duration in Patients with Early Persistent Atrial Fibrillation Who Underwent Radiofrequency Catheter Ablation

Establishment and Verification of a Nomogram for Predicting the Probability of New-Onset Atrial Fibrillation after Dual-Chamber Pacemaker Implantation.

An Echocardiographic Model for Predicting the Recurrence of Paroxysmal Atrial Fibrillation after Circumferential Pulmonary Vein Ablation.

Left Atrial Appendage Circular RNAs Are New Predictors of Atrial Fibrillation Recurrence after Surgical Ablation in Valvular Atrial Fibrillation Patients

The effect of non-insulin-based insulin resistance indices on the prediction of recurrence in patients with atrial fibrillation undergoing radiofrequency catheter ablation